Skip to content
★ Sign in to follow
Biodyne Co., Ltd. logo

Biodyne Co., Ltd. Stock: price and insider trades · South Korea

바이오다인

KR·Mcap ₩176.9BHealth Care

No insider purchase over the last 90 days. The latest, by 양근호, was filed 13 Jul 2026.

Biodyne Co., Ltd.: what insiders have been doing

Biodyne Co., Ltd., classified in the Health Care sector, is a listed company. Its insiders report their share dealings to DART (FSS). From 23 October 2025 to 23 October 2026, the disclosure feed for Biodyne Co., Ltd. logged 8 filings by 3 insiders.

Only purchases show up on the open market, 6 purchases in all, filed by 3 insiders. The totals exclude 6 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Among those who bought: 2 board members and 1 chief executive.

The last purchase on record was published on 13 July 2026, which is 118 days ago. The median gap between a trade and its publication by DART (FSS) is 7 days. This delay matters because a trade only becomes useful information once it is public.

With 8 filings in twelve months, the company is more active than the median of 7 filings across the 2,650 companies we follow on the same exchange. Over the whole record (from 2021), the tally stands at 8 purchases and 10 sales.

In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.

Insider Decl.
28
Thresholds
n/a
Buy Volume
€667,305
8 ops. · all time
Sell Volume
€39M
10 ops. · all time

Who traded when

BuySale
임욱빈3 buys1 sale
양근호2 buys
고유라1 buy

Since the insiders bought

  • Filed 13 Jul 2026 · 118 days ago · €14k
    -26.5%
    Entry ₩7,930 · Close 23 Oct 2026 ₩5,830
  • Filed 04 Jun 2026 · 157 days ago · €437k
    -40.3%
    Entry ₩9,760 · Close 23 Oct 2026 ₩5,830
  • Filed 27 Nov 2025 · 346 days ago · €8,289
    -23.0%
    Entry ₩15,770 · Close at T+90 ₩12,150

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Fundamental score
Ranked 12,922 of 26,897 companies
52.5
score / 100
Value
31
Quality
74
FCF yld-2.9%
Earn yld0.5%
EV/EBITDA·
ROE3.3%
Gross mgn64%
Net mgn12%
Debt/EBITDA0.0x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩6,000
Analyst consensus
·
Income statement
Revenue₩7B
Gross profit₩4.5B64% margin
EBITDA₩2.2B31% margin
Net income₩851.6M21.2% margin
Valuation
PER (forward)25.8x
Beta1.06
Balance sheet & cash
Market cap₩176.9B
Total debt₩11M
Free Cash Flow-₩4.8B
Debt / Equity0%
Profitability & ownership
ROE3.3%
ROA-2.1%
% insiders42.1%
% institutions1.0%
Last declaration on 13 July 2026
Declarations29 total
  • Other
    Other(filed)
    0DART
  • ▲
    사내이사Executives(filed)
    €14kest.0DART
    3,000 sharesShareKRXDART:20260713000055
    Canonical exit: 11 Oct 2026 (T+90)
  • ●
    대량보유자Executives(filed)
    0DART
    KRXDART:20260706000016
  • ▲
    대표이사Executives(filed)
    €103kest.0DART
    19,617 sharesShareKRXDART:20260706000015
    Canonical exit: 4 Oct 2026 (T+90)
  • ▲
    Executives
    €437kest.0DART
    77,542 sharesShareKRXDART:20260604000045
    Canonical exit: 25 Aug 2026 (T+90)
  • ●
    Executives
    0DART
    0KRXDART:20260515002468
  • ▲
    Executives
    €57kest.0DART
    6,800 sharesKRXDART:20260219001095
    Canonical exit: 13 May 2026 (T+90)
  • ▲
    사내이사Executives(filed)
    €48kest.0DART
    5,800 sharesShareKRXDART:20251127000260
    Canonical exit: 25 Feb 2026 (T+90)
  • ▲
    사내이사Executives(filed)
    €8,289est.0DART
    1,000 sharesShareKRXDART:20251127000253
    Canonical exit: 25 Feb 2026 (T+90)
  • ▼
    대량보유자Executives
    €10.4Mest.0DART
    1,060,258 sharesKRXDART:20250808000589
  • ▼
    Executives
    €2.0Mest.0DART
    148,000 sharesKRXDART:20241031000336
  • ▲
    사내이사Executives
    0DART
    ShareKRXDART:20240912000151
    Canonical exit: 8 Dec 2024 (T+90)
  • ▲
    사내이사Executives
    0DART
    ShareKRXDART:20240912000154
    Canonical exit: 8 Dec 2024 (T+90)
  • ▼
    Executives
    €1.3Mest.0DART
    148,000 sharesKRXDART:20230823000343
  • ▼
    Executives
    €1.2Mest.0DART
    148,000 sharesKRXDART:20230814000495
  • ▼
    Executives
    €1.2Mest.0DART
    148,000 sharesKRXDART:20230814000490
  • ▼
    Executives
    €1.2Mest.0DART
    148,000 sharesKRXDART:20230814000471
  • ●
    사내이사Executives
    0DART
    ShareKRXDART:20230802000175
  • ●
    사내이사Executives
    0DART
    ShareKRXDART:20230503000373
  • ●
    사내이사Executives(filed)
    0DART
    ShareKRXDART:20220613000054
  • ●
    사내이사Executives(filed)
    0DART
    ShareKRXDART:20220613000055
  • ●
    사내이사Executives(filed)
    0DART
    ShareKRXDART:20220613000053
  • ▼
    Executives(filed)
    €3.2Mest.0DART
    148,000 sharesKRXDART:20211028000313
  • ▼
    Executives(filed)
    €4.7Mest.0DART
    148,000 sharesKRXDART:20210617000158
  • ▼
    Executives(filed)
    €6.7Mest.0DART
    148,000 sharesKRXDART:20210323000860

25 of 29 declarations

About Biodyne Co., Ltd.

BioDine is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in developing innovative solutions for the medical sector.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations